AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effects of Neuromodulation in Laryngeal Dystonia

RecruitingNAAges 21 Years - 85 YearsAllMGH Institute of Health Professions
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Laryngeal dystonia (LD) causes excessive vocal fold abduction (opening) or adduction (closing) leading to decreased voice quality, job prospects, self-worth and quality of life. Individuals with LD often experience episodic breathy voice, decreased ability to sustain vocal fold vibration, frequent pitch breaks and in some cases, vocal tremor. While neuroimaging investigations have uncovered both cortical organization and regional connectivity differences in structures in parietal, primary somatosensory and premotor cortices of those with LD, there remains a lack of understanding regarding how the brains of those with LD function to produce phonation and how these might differ from those without LD. Intervention options for people with LD are limited to general voice therapy techniques and Botulinum Toxin (Botox) injections to the posterior cricoarytenoid (PCA) and/or TA (thyroarytenoid)

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age range is 21-85 years * Diagnosis of Laryngeal Dystonia (LD) * Subject is able to give informed consent * Symptoms at worst severity if receiving botulinum toxin injections * Subject has signed the consent form Exclusion Criteria: * Other forms of dystonia * Vocal fold pathology or paralysis * Essential tremor * Laryngeal cancer or other neurologic conditions with medications affecting the central nervous system * History of laryngeal surgery * Adults lacking the ability to consent or complete the assessments and intervention * Seizure in the last 2 years * Contraindications to rTMS
๐Ÿ’Š

What it tests

  • repetitive transcranial magnetic stimulation (rTMS)
  • sham rTMS
๐Ÿ“

Where

1 site
Teresa J Kimberley
Boston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy